Overall, our results indicate that daidzein attenuates renal dysfunction, fibrosis, glomerulosclerosis, and apoptosis in the UUO model of OVX rats through a decrease in AT1R activation, an increase in MasR function, and inhibition of miR-33a and miR-27a overexpression. The gene discussed is MAS1L; the disease is glomerulosclerosis.